Cell type specific gene expression of mid brain dopaminergic neurons reveals molecules involved in their vulnerability and protection.
Chung, C. Y., Seo, H., et. al.
Hum Mol Genet., 2005
12
Abnormal APP, cholinergic and cognitive function in Ts65Dn Down’s model mice.
Seo, H., Isacson, O.
Exp. Neurol., 2005
13
Generalized brain and skin proteasome inhibition in Huntington’s disease.
Seo, H., et. al.
Annals Neurol., 2004
14
Generation of a human iPSC line from a Parkinson's disease patient with a novel CHCHD2 mutation (p.R145Q)
서혜명
STEM CELL RESEARCH, 2024
15
Multicomponent metal-organic framework nanocomposites for tumor-responsive synergistic therapy
서혜명
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2023
16
Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells
서혜명
NATURE PROTOCOLS, 2022
17
Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease
서혜명
PROGRESS IN NEUROBIOLOGY, 2021
18
Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model
서혜명
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021
19
Brain cells derived from Alzheimer's disease patients have multiple specific innate abnormalities in energy metabolism
서혜명
MOLECULAR PSYCHIATRY, 2021
20
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease